Literature DB >> 17008042

Acute encephalitis with refractory, repetitive partial seizures: case reports of this unusual post-encephalitic epilepsy.

Yoshiaki Saito1, Yoshihiro Maegaki, Riina Okamoto, Kaeko Ogura, Masami Togawa, Yukiko Nanba, Takehiko Inoue, Yukitoshi Takahashi, Kousaku Ohno.   

Abstract

We report on three acute encephalitis patients with refractory, repetitive partial seizures (AERRPS). All three suffered acute febrile episodes associated with status epilepticus, which necessitated high-dose barbiturate therapy under artificial ventilation for several weeks. Electroencephalography (EEG) revealed a predominance of diffuse epileptiform discharges initially, subsequently developing into periodic bursts of these discharges. Reduction of the barbiturate dosage resulted in clinical and subclinical partial seizures appearing repetitively in clusters. Prolonged fever persisted for 2-3 months, even several weeks after normalization of cell counts in the cerebrospinal fluid. The EEG showed an improvement after resolution of this fever, and seizures became less frequent, although still intractable. Oral administration of high-dose barbiturate and benzodiazepines were partially effective during the acute phase, and a barbiturate dependency, lasting for years, was noted in one patient. Steroid administration was effective in stopping the febrile episodes in one patient, with concurrent improvement in seizure control. Magnetic resonance imaging showed enhancement of bitemporal cortical areas in one patient, and high signal intensity on T2 weighted image in the bilateral claustrum in another patient. Diffuse cortical atrophy appeared within two months after the onset of encephalitis in all patients. The evolution of the seizures and EEG findings suggested a high degree of cortical excitability in AERRPS. In this report, we propose a tentative therapeutic regimen for seizure control in this condition. We also hypothesize that a prolonged inflammatory process exists in the cerebral cortex with AERRPS, and may be pivotal in the epileptogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008042     DOI: 10.1016/j.braindev.2006.08.005

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  7 in total

1.  Mumps virus encephalitis with symmetric claustrum lesions.

Authors:  K Ishii; H Tsuji; A Tamaoka
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-09       Impact factor: 3.825

2.  Acute encephalitis with refractory, repetitive partial seizures: A case report and literature review.

Authors:  Bin Zhang; Lin Wang
Journal:  Exp Ther Med       Date:  2016-09-27       Impact factor: 2.447

3.  Claustrum damage and refractory status epilepticus following febrile illness.

Authors:  Stefano Meletti; Jana Slonkova; Iva Mareckova; Giulia Monti; Nicola Specchio; Petr Hon; Giada Giovannini; Vaclav Marcian; Annalisa Chiari; Petr Krupa; Nicola Pietrafusa; Dagmar Berankova; Michal Bar
Journal:  Neurology       Date:  2015-09-04       Impact factor: 9.910

4.  A boy with non-herpes simplex acute limbic encephalitis and antiglutamate receptor antibodies.

Authors:  Hisashi Kawashima; Chiako Ishii; Gaku Yamanaka; Hiroaki Ioi; Kouji Takekuma; Masaaki Ogihara; Akinori Hoshika; Yukitoshi Takahashi
Journal:  Clin Med Insights Case Rep       Date:  2011-08-10

5.  New-Onset Refractory Status Epilepticus with Claustrum Damage: Definition of the Clinical and Neuroimaging Features.

Authors:  Stefano Meletti; Giada Giovannini; Giuseppe d'Orsi; Lisa Toran; Giulia Monti; Rahul Guha; Andreas Kiryttopoulos; Maria Grazia Pascarella; Tommaso Martino; Haris Alexopoulos; Martha Spilioti; Jana Slonkova
Journal:  Front Neurol       Date:  2017-03-27       Impact factor: 4.003

6.  Effect of Antiepileptic Drugs for Acute and Chronic Seizures in Children with Encephalitis.

Authors:  Kuang-Lin Lin; Jainn-Jim Lin; Shao-Hsuan Hsia; Min-Liang Chou; Po-Cheng Hung; Huei-Shyong Wang
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

Review 7.  Neurocritical care and target immunotherapy for febrile infection-related epilepsy syndrome.

Authors:  Hiroshi Sakuma; Asako Horino; Ichiro Kuki
Journal:  Biomed J       Date:  2020-04-21       Impact factor: 4.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.